NCT02731495View on ClinicalTrials.gov

Effect of Epigallocatechin -3-gallate Supplementation in Traumatic Brain Injury Patients

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

March 31, 2015

Primary Completion Date

November 30, 2015

Study Completion Date

January 31, 2016

Conditions
Traumatic Brain Injury
Interventions
DIETARY_SUPPLEMENT

EGCG

EGCG (Epigallocatechin -3-gallate)

DIETARY_SUPPLEMENT

Placebo (deionized water)

Trial Locations (1)

19435

NNFTRI clinic, Tehran

All Listed Sponsors
collaborator

Tehran University of Medical Sciences

OTHER

lead

National Nutrition and Food Technology Institute

OTHER

NCT02731495 - Effect of Epigallocatechin -3-gallate Supplementation in Traumatic Brain Injury Patients | Biotech Hunter | Biotech Hunter